Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kai Wucherpfennig, M.D., Ph.D.

Concepts (763)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Kai Wucherpfennig's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Kai Wucherpfennig has written about over time.
HLA-DR2 Antigen, 17 publications between 1994 and 2011, average publication date October 2000. Autoantigens, 17 publications between 1991 and 2013, average publication date September 2003. Peptides, 31 publications between 1995 and 2025, average publication date June 2005. Autoimmunity, 16 publications between 1994 and 2018, average publication date October 2005. T-Lymphocytes, 59 publications between 1990 and 2024, average publication date March 2006. Receptors, Antigen, T-Cell, 50 publications between 1990 and 2023, average publication date September 2006. Antigen Presentation, 20 publications between 1994 and 2025, average publication date November 2006. HLA-D Antigens, 11 publications between 1995 and 2013, average publication date December 2006. Histocompatibility Antigens Class II, 25 publications between 1994 and 2025, average publication date August 2007. Histocompatibility Antigens, 5 publications between 2004 and 2014, average publication date February 2010. CD4-Positive T-Lymphocytes, 23 publications between 1993 and 2025, average publication date June 2010. T-Lymphocytes, Cytotoxic, 11 publications between 1999 and 2020, average publication date January 2013. CD8-Positive T-Lymphocytes, 24 publications between 2001 and 2024, average publication date March 2017. Antigens, Neoplasm, 13 publications between 2002 and 2025, average publication date July 2017. Killer Cells, Natural, 15 publications between 2005 and 2024, average publication date October 2017. Histocompatibility Antigens Class I, 17 publications between 2004 and 2024, average publication date February 2018. Immunotherapy, 26 publications between 1997 and 2024, average publication date June 2018. Neoplasms, 22 publications between 2001 and 2024, average publication date June 2019.

To see the data from this visualization as text, click here.
Wucherpfennig's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (763)
Explore
_
Co-Authors (226)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.